Evidence map›Paper›PMID 32206728›Full record

ArticleGlobal health research and policy2020

China-UK partnership for global health: practices and implications of the Global Health Support Programme 2012-2019.

Xiaohua Wang, Peilong Liu, Tongwu Xu, Yan Chen, Yang Yu, Xun Chen, Jingyi Chen, Zhaoyang Zhang

Abstract read
In one paragraph

Article in Global health research and policy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaohua WangCenter for Project Supervision and Management, National Health Commission of the People's Republic of China, Beijing, 100044 China.ORCID 0000-0003-4341-9541
Peilong Liu2School of Public Health, Peking University, Beijing, 100191 China.
Tongwu Xu3Graduate School of the Chinese Academy of Social Sciences, Beijing, 102488 China.
Yan Chen4School of Health Sciences/Global Health Institute, Wuhan University, Wuhan, 430071 China.
Yang YuCenter for Project Supervision and Management, National Health Commission of the People's Republic of China, Beijing, 100044 China.
Xun ChenCenter for Project Supervision and Management, National Health Commission of the People's Republic of China, Beijing, 100044 China.
Jingyi ChenCenter for Project Supervision and Management, National Health Commission of the People's Republic of China, Beijing, 100044 China.
Zhaoyang ZhangCenter for Project Supervision and Management, National Health Commission of the People's Republic of China, Beijing, 100044 China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Over the past few decades, a series of major challenges to global health have successively emerged, which call for China's deeper engagement in global health governance. In this context, the China-UK Global Health Support Programme (GHSP) was launched in 2012 with about 12 million pounds funded by the United Kingdom. Objectives: The GHSP was expected to explore a new type of China-UK partnership to strengthen the cooperation in global health, and enhance China's capacity to engage in global health governance and provide effective development assistance in health (DAH), in order to jointly improve global health outcomes. Programme design and implementation: The GHSP was programmed to support capacity building activities in Chinese experience distillation, DAH, global health governance and pilot partnership at national and institutional levels between October 2012 and March 2019. These activities were assigned to different project implementing agencies (PIAs) and their project cooperative agencies (PCAs) or pilot areas, and were then implemented under the guidance and management by the strategic oversight committee and the project management office of GHSP respectively. Main achievements: At the national level, the GHSP held five rounds of China-UK high-level dialogues, conducted studies on China Global Health Strategies to provide robust evidence for developing and issuing relevant national policies, and supported the establishment of the China Global Health Network. At the institutional level, the GHSP funded a series of activities in research, training, international exchange and pilots etc., produced a large number of high-quality research outputs and policy briefings, cultivated a group of PIAs and individual researchers, facilitated the partnership building between the PIAs and PCAs, enhanced the practical ability of Chinese institutions to conduct overseas DAH, and improved the health service delivery and outcomes in pilot areas of three Asian and African countries. Policy implications: In the GHSP, China and UK have established a good model for North-South Cooperation and the programme facilitated the 2030 Agenda for Sustainable Development by building a new type of bilateral partnership and carrying out triangular cooperation practices. This model has demonstrated huge potential for cooperation through partnership and can also be referred to by other countries to develop bilateral partnerships.

Indexed as

International CooperationCapacity BuildingChinaDelivery of Health CareGlobal HealthUnited KingdomChinaGlobal health governanceGlobal health policyHealth project managementPartnershipUK

Identifiers

PMID32206728
PMCPMC7083009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.